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In adaptive immunity, organisms produce neutralizing antibodies
(nAbs) to eliminate invading pathogens. Here, we explored whether
viral neutralization could be attained through the physical disrup-
tion of a virus upon nAb binding. We report the neutralization
mechanism of a potent nAb 8C11 against the hepatitis E virus (HEV),
a nonenveloped positive-sense single-stranded RNA virus associated
with abundant acute hepatitis. The 8C11 binding flanks the protru-
sion spike of the HEV viruslike particles (VLPs) and leads to tre-
mendous physical collision between the antibody and the
capsid, dissociating the VLPs into homodimer species within 2 h.
Cryo-electronmicroscopy reconstruction of the dissociation interme-
diates at an earlier (15-min) stage revealed smeared protrusion
spikes and a loss of icosahedral symmetry with the capsid core
remaining unchanged. This structural disruption leads to the pres-
ence of only a few native HEV virions in the ultracentrifugation
pellet and exposes the viral genome. Conceptually, we propose a
strategy to raise collision-inducing nAbs against single spike moie-
ties that feature in the context of the entire pathogen at positions
where the neighboring space cannot afford to accommodate an
antibody. This rationale may facilitate unique vaccine development
and antimicrobial antibody design.
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Neutralizing antibodies (nAbs) play key roles in immuneclearance and the subsequent evocation of the host-
protective response during pathogenic invasion. NAbs mediate
viral neutralization by blocking virus attachment and, in turn,
prohibiting any conformational changes required for viral mem-
brane fusion or the release of progeny virions (1–5). These com-
plicated procedures initiate an immune response, clearing the
virus through the activation of various integrated phagocytotic
and degradative host-immune pathways (1–3). Indeed, numerous
signaling pathways and effectors are associated with antibody-
mediated immune clearance and protection: antibody-mediated
endocytosis, antibody-dependent cell-mediated cytotoxicity, and
complement-dependent cytotoxicity, among others (4, 6). These
processes are energetically demanding and exhaust the host
cell’s supplies, rendering the cell susceptible to secondary in-
flammatory events (7).
Physical collisions at the molecular level often induce dramatic
structural and conformational changes and rearrangements in
multisubunit protein ensembles (8, 9). Studies have shown that
virus dissociation can be influenced in vitro by physical distur-
bances, such as high pressure or extreme pH (10–12). Indeed, work
on the picornaviruses has shown that binding of nAbs destabilizes
the virion and releases the viral genome, even though the struc-
tural integrity of the resultant capsid is maintained (13–17). This
raises the question as to whether a physical collision created while
the antibody is engaged on the surface of the pathogen could
eliminate the pathogen or render it harmless in situ. We surmised
that such a mode of pathogen elimination would be more efficient
than the complex pathways activated through conventional im-
mune processes of viral clearance.
The hepatitis E virus (HEV), associated with abundant acute
hepatitis, is a positive-sense single-stranded RNA virus, con-
sisting of a nonenveloped icosahedral capsid (27–34 nm) and
7.2 kb of genomic RNA (18). The HEV genome includes 3
ORFs (ORF1–3) of which ORF2 encodes 2 ∼660-amino acid (aa)
translated proteins via 2 alternative start codons: the capsid pro-
tein (pORF2) (18) and a secreted form of ORF2 (ORF2S) (19).
Crystal and cryo-electron microscopy (cryo-EM) structures of the
HEV capsid proteins have been extensively elucidated, including
the HEV protruding domain (E2s, amino acids 455–602) and the
T = 1 and T = 3 VLPs (10, 20–25). Monomeric pORF2 is com-
posed of a shell domain (S domain and aa 118–317), a middle
domain (M domain and aa 318–451), and a protrusion domain
(P domain and aa 452–606). The E2s domain folds into a
typical β-barrel, 2 of which tightly form a homodimeric spike
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that protrudes from each of the icosahedral 2-fold axes of the
capsid. A flexible groove region in E2s is crucial in the binding
of nAbs and is proposed to be the cellular receptor-binding
region (26).
We previously reported a crystal structure of the HEV E2s
domain in the complex with nAb 8C11. This nAb conferred
potent neutralizing ability in both our HEV cell model and an
animal model through binding to a conformational neutralization
epitope flanking the protrusion structure (23). Intriguingly, the
light chain of 8C11 Fab in the crystal structure physically collides
with the neighboring M domain of pORF2 when the complex
structure is superimposed on the whole HEV T = 1 VLP crystal
structure (23). We hypothesized that such a collision could render
the virus ineffective through physically disrupting its structure. To
further understand the consequence of this structural clash on the
virus, here, we investigate the dynamic structural variation of HEV
VLP during binding with 8C11 Fab using size-based character-
ization and cryo-EM 3D reconstruction. We found a tremendous
structural dissociation of the 8C11-bound VLP that was sub-
stantially affected by time and antibody dosage. The binding of
8C11 initiated a complete disordering of the VLP rim structure in
the early stages (∼15 min) of the 8C11-VLP interaction with no
structure resolvable thereafter. Similar capsid deconstruction
was also observed for the native HEV virion as determined
using a fluorescence-staining RNA release assay. We, thus,
propose an immune-favorable rationale for raising collision-
inducing nAbs for virus neutralization and offer a strategy for
such antibody generation.
Results
The 8C11 Binding Induces a Physical Collision on HEV VLPs and
Dissociates the Particles. We previously reported the crystal
structure (PDB no. 3RKD) of HEV nAb 8C11 in complex with
E2s (P domain) at a binding ratio of 2 Fab to 1 E2s dimer (Fig. 1A)
(23). When we fitted the cocrystal structure into the known density
maps of HEV T = 1 (generated from the crystal structure of PDB
no. 2ZZQ) and T = 3 VLPs (EMDB no. 5173), respectively (24),
the 8C11 Fab binding showed enormous clashes with the neigh-
boring pORF2 monomers in both models (Fig. 1 A and B). The
Fabs overlaid with the T = 3 capsid shell (Fig. 1B) more con-
spicuously than with the T = 1 capsid (Fig. 1A) because of a higher
volume of T = 3 particle involvement in the structural overlapping
and a flatter surface curvature. T = 3 VLPs are believed to be
virion-sized particles assembled with the involvement of RNA
molecules (24). In the superimposed models, about 4,456 Å3 of
each Fab 8C11 (total ∼18,660-Å3 volume) in the E2:8C11 crystal
structure overlaps with the T = 1 VLP model, whereas, on the T = 3
map due to the existence of 3 different spatial relationships between
Fab and P (and M) domain(s) of the adjacent E2s (24), the volume
of overlapping density between the Fab 8C11 and the neighboring
pORF2 monomers was 7,721, 4,779, and 2,311 Å3, respectively.
These results indicate that the binding modality of 8C11 in the
8C11:E2s cocrystal structure may cause tremendous spatial clashing
with its neighboring viral capsid protein, given that it directly binds
to the T = 1 or T = 3 icosahedral shell.
To observe the subsequent events following 8C11 binding to
HEV particles, HEV ORF2 aa112-608 (p495) from a genotype 1
strain was expressed and purified from insect cells. The VLPs were
homogenous, with an ∼20- to 30-nm diameter in neutral solution
(SI Appendix, Fig. S1) as described in our previous studies (27).
The obtained HEV VLPs were then used to prepare an immune
complex with the antigen-binding (Fab) fragments of nAb 8C11
(VLP:8C11). Another nAb 3B6, which recognizes the top region
of the P domain, was recruited to prepare a control immune
complex (VLP:3B6) (28). Both monoclonal antibodies (mAbs)
8C11 and 3B6 showed high binding and neutralizing efficiency
against HEV VLPs and the native virus before immune com-
plex preparation (SI Appendix, Fig. S2). It should be mentioned
that we ever contrived to generate T = 3 VLPs (ORF2 aa14-608)
in insect cells according to Li’s protocol (29), however, the
purified sample was not abundant and poorly homogeneous
for similar biochemical and structural analyses as performed at
T = 1 VLPs.
Immune complexes of VLP:8C11 and VLP:3B6 were prepared
in a 1:2 molar ratio (p495:Fab) to have a surplus of Fab and in-
cubated at 37 °C for 2 h. The control sample (VLP:3B6) resolved
as 2 major peaks in the high-performance size-exclusion chro-
matography (HPSEC) profile with retention volumes of 6.8 and
8.8 mL corresponding to the immune complex (VLP:3B6) and the
excess 3B6 Fab, respectively; this was compared with 7.0 and
9.2 mL for VLP and Fab alone, respectively (Fig. 1C). Strikingly,
most of the VLP and 8C11 Fab mixture exhibited a median
component (8.3 mL) between the supposed particle complex (6.7 mL,
similar with VLP:3B6) and the excess 8C11 Fab (9.1 mL) (Fig. 1C).
The amount of the median species was ∼8.7 times that of
the supposed particles in terms of integrated peak areas under
the HPLC curve. We speculated that the smaller species was the
disrupted product generated by the physical collision between
8C11 Fab and VLPs. Moreover, both peaks were confirmed to be
immune complexes containing p495 and Fab in the SDS/PAGE
(Fig. 1E).
We next examined the morphology of these immune complexes
in negative-staining transmission electron microscopy (TEM). The
control VLP:3B6 had a larger particle size than the HEV VLPs
(Fig. 1 F and H), whereas, only a few VLP-sized particles could be
observed in the VLP:8C11 sample (Fig. 1G), consistent with the
HPSEC results. The predominantly smaller p495:8C11 complex
was further characterized as about 7.5 S (about 160 kDa in c[M]
calculation, supposed to be 2 p495 binding with 2 8C11 Fabs)
through sedimentation velocity (SV) tests in analytical ultracen-
trifugation (Fig. 1D and SI Appendix, Fig. S3). Taken together,
the binding of 8C11 with HEV VLPs led to the dissociation of
VLPs into p495 homodimer, presumably due to the physical
collision between the 8C11 and the capsid as hypothesized in
the structural analysis.
The 8C11-Bound VLPs Are Disrupted in a Concentration- and Time-
Dependent Manner. We then investigated the VLP dissociation
potential with different starting concentrations of 8C11 Fab. We
surmised that the amount of 8C11 Fab input could influence the
dissociation efficacy of the VLP:8C11 complex. We found that
less 8C11 (p495:8C11 molar ratio = 1:1) resulted in only partial
(∼57%) complex dissociation, whereas increased Fab ratios (1:2
and 1:4) led to complete dissociation (Fig. 2A). For the 1:2 Fab
ratio, when the incubation time was reduced to 15 min, a pre-
dominant VLP-sized peak was retained with the dissociated
components accounting for only 1-quarter of the VLP-sized peak
in the HPSEC profile (Fig. 2B). Longer reaction times (30 min to
2 h) as expected led to higher rates of dissociation (Fig. 2B).
Additionally, the treatment of intact 8C11 antibody induced sim-
ilar dissociation consequence upon HEV VLPs as its Fab moiety
(SI Appendix, Fig. S4).
We next sought to track the dissociation of VLPs at different
time points by cryo-EM analysis. HEV VLPs were mixed with
Fab 8C11 (p495:8C11, 1:2) for 15, 30, 60 min, and 2 h and then
plunge frozen for the cryo-EM image collection (Fig. 2 C–H,
Left). HEV VLP in the complex with Fab 3B6 served as a control,
and the cryo-EM images and 2D classification results showed
identifiable VLPs and complex features (Fig. 2 C and D). Con-
sistent with the HPSEC results shown in Fig. 2B, VLPs in the
presence of 8C11 for 15 min showed particle sizes that were
overall similar to that of VLPs (Fig. 2C) and substantially smaller
than the size of VLP:3B6 (Fig. 2D); albeit there was a higher
density of particles at the rim in response to 8C11 binding (Fig.
2E). This binding is consistent with the 2 modes of binding noted
for 8C11 (binds to the flank side of protrusion domain, Fig. 1A)
26934 | www.pnas.org/cgi/doi/10.1073/pnas.1916028116 Zheng et al.
D
ow
nl
oa
de
d 
at
 X
ia
m
en
 U
ni
ve
rs
ity
 o
n 
M
ar
ch
 5
, 2
02
0 
and 3B6 [proposed to bind the top of protrusion spike of the
particles in terms of its epitope mapping (28)]. With a longer in-
cubation (>15 min), the density of the outside rim of the particle
blurred with fewer intact particles screened out from the 2D
classification (Fig. 2 E–H and SI Appendix, Table S1). By 2 h, few
particles could be detected in both the HPSEC (Fig. 2A) and the
cryo-EM images (Fig. 2 H, Left), and the averaged 2D classes
from the available particles exhibited poor morphology (Fig. 2H).
These results suggest that physical collision imposed by 8C11
binding leads to VLP dissociation within 2 h.
Cryo-EM Reconstruction of the Disassembling Intermediates of
the 8C11-Bound VLPs. The cryo-EM structures of HEV VLP,
VLP:8C11 (15-min incubation), and VLP:3B6 were further de-
termined at 3.4-, 3.6-, and 7.2-Å resolutions, respectively, with
Relion (30) (SI Appendix, Fig. S5 and Table S2). The structure of
VLP:3B6 at a medium resolution showed the proposed binding to
the top of the protrusion spike as indicated by epitope mapping in
our previous study (28). We then built the atomic model for HEV
VLP, which exhibits T = 1 icosahedral symmetry with 60 copies
of the p495 subunit arranged into 30 dimeric protruding spikes
Fig. 1. Physical collision created by 8C11 binding causes HEV VLPs to dissociate. (A and B) Fitting of the crystal structure of the E2s:8C11 complex (PDB no.
3RKD) to density maps of HEV T = 1 (generated from the crystal structure of PDB no. 2ZZQ) (A) and T = 3 (EMDB no. EMD-5173) (B) VLP structures, respectively.
The E2s:8C11 complex model, rendered in cartoon mode, was fitted to VLPs according to the E2s part (green), and the resultant overlapping moieties be-
tween VLPs and 8C11 are shown in semitransparent surface mode in teal (heavy chain) and marine (light chain). The cartoons above the Right depict
structural overlapping domains of p495 with Fab 8C11, T = 1 has a single interaction scenario where the M domain and neighboring P domain are overlapping
to Fab with a volume of 4,456 Å3, whereas T = 3 with 2 dimer forms A-B, C-C in its icosahedral lattice has 3 scenarios (24), (1) M domain, neighboring M and P
domains creating an overlapping volume of 7,721 Å3, (2) M domain and neighboring P domain, 4,779 Å3, (3) neighboring P domain, 2,311 Å3. (C) HPSEC
analysis of HEV VLPs mixed with 8C11 or 3B6 Fab. An extra peak (indicated by the black arrow, named the smaller complex) demonstrates the presence of a
species that is larger than 8C11 Fab but far smaller than VLPs in the VLP:8C11 sample. VLPs were, thus, almost depleted as compared with the control. (D)
Determination of the molecular weight of the smaller complex in solutions through the sedimentation velocity test. The smaller complex in the VLP:8C11
HPSEC profile was harvested. The c(S) and c(M) profiles suggested the smaller complex fraction is predominantly the p495 dimer in the complex with 2 8C11 Fabs
(3.4S, 160.3 kDa) in addition to the surplus Fabs (7.5S, 47.9 kDa). (E) SDS/PAGE analysis of HEV VLPs mixed with 8C11 Fabs. The smaller complex fraction was
resolved in lane 4, suggesting a complex comprising both p495 and 8C11 Fab. (F–H) Representative negative-staining micrographs of HEV VLPs (F), VLP: 8C11 (G)
and VLP: 3B6 (H), which manifested no detectable particle for the VLP:8C11 sample.
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located at each icosahedral 2-fold axis (Fig. 3A). The densities
attributable to the residue backbones and side chains were clearly
recognizable for all 3 of the S, M, and P domains (Fig. 3 B and C);
these are structurally identical to those previously reported in the
crystal structures of the HEV capsid protein (21, 22, 24, 25) (SI
Appendix, Fig. S6) and used in our structural analysis of the
E2s:8C11 immune complex (Fig. 1A).
It is striking that the cryo-EM map of the 8C11-bound VLP also
demonstrated an overall high resolution of 3.6 Å. However, only
the S and M domains were of high resolution with an intact and
identical atomic model to that shown in the structure of HEVVLP
(SI Appendix, Fig. S6). The moieties corresponding to the P do-
main and Fab 8C11, on the other hand, were extremely disordered
in the density map with some residual, albeit irregular, density
around the core shell constituted by the S and M domains (Fig.
3 D–F). By comparison, the cryo-EM structure of VLP:3B6 had
intact VLP binding, with 60 separate Fabs and typical resolution
of the outward Fab components of the shell (Fig. 3 G and H).
These results together indicate that 8C11 binding to VLP bumps
against neighboring p495 subunits and leads to a disordered
rearrangement of the P domains, destroying their icosahedral
symmetry.
To investigate if there was any order to the 8C11-bound P
domain, we undertook a structure reconstruction with the same
dataset of the VLP:8C11 complex without any icosahedral sym-
metry (C1). The resultant density map, albeit at a lower resolution
(∼25 Å), showed that the 8C11-bound P domains were completely
disordered, whereas the core shell comprising the M and S
domains remained intact as an icosahedral structure (SI Appendix,
Fig. S7). We propose that the status of the 8C11-bound VLP at
15 min may represent VLP disassembling intermediates—8C11 is
still bound with the P domain and the P domain still linked to the M
domain—and surmise that these intermediates probably further
dissociate into smaller species with longer incubation time (Fig. 2A).
The 8C11 Binding Disintegrates Native HEV and Exposes the Genomic
RNA. Next, we sought to examine whether such disassembly in-
duced by 8C11 binding could be replicated with native HEV. To
date, we still cannot acquire an adequate sample of native HEV
for structure determination due to the low efficiency of the HEV
cell culture system (31–33). Nonetheless, we were able to prepare
native HEV samples from experimental monkeys challenged with
native HEV as described in our previous studies (33). First, we
checked the integrity of the native HEV after incubation with
8C11 for 2 h by an ultracentrifugation/precipitation-coupling
genome-based qPCR assay; this was based on the presumption
that 8C11 binding would disassemble the native HEV caused by
physical disruption (Fig. 4A) and prevent the disintegrated viral
constituents (with lower sedimentation coefficient than the intact
native virion) from pelleting by ultracentrifugation. As expected,
more than 90% of the native HEV (1.39 × 107 copies of RNA
genome per milliliter as compared with the initial virus input of
1.50 × 107 copies of RNA genome per milliliter) in the control
sample (mAb 3B6 and buffer only) was harvested via ultracentri-
fugation, whereas only 52% of the native HEV (7.93 × 106 copies
of RNA genome per milliliter) pelleted in the 8C11-treated HEV
Fig. 2. Dissociation extent of HEV VLPs depends on 8C11 concentration and incubation time. (A) The 8C11 concentration-dependent dissociation of HEV
VLPs. HEV VLPs were mixed with 8C11 at various p495:8C11 molar ratios (1:1, 1:2, and 1:4) for 2 h and analyzed by HPSEC analysis. Conspicuously, the
p495:8C11 ratio of 1:4 completely dissociated HEV VLPs into the smaller species, which reflects law of mass action of 8C11 upon VLP dissociation. (B) In-
cubation time-dependent dissociation of HEV VLPs. HEV VLPs were mixed with 8C11 at an equal molar ratio (1:1) and incubated for 15 min and 2 h. The
dissociated species (retention volume of ∼8.5 mL) became a predominant peak in the HPSEC profiles as the incubation time extended from 15 min to 2 h.
(C and D) Cryo-EM analysis of HEV VLPs alone and mixed with mAb 3B6 for 2 h served as a control. (E–H) Cryo-EM analysis of HEV VLPs mixed with 8C11 for
15 min to 2 h. For each cryo-EM analysis, 1 representative raw cryo-EM image (Left) and the Top 2 classes of 2D classification (Right 2 panels) are shown. The
number of visible particles in the cryo-EM images decreases with incubation time as does the density volumes of the rim of particle classes.
26936 | www.pnas.org/cgi/doi/10.1073/pnas.1916028116 Zheng et al.
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sample, significantly less than the control sample (Fig. 4B). These
findings indicated that 8C11 may also impose capsid disassembly
on native HEV as on VLPs.
Finally, we monitored the dynamic process of HEV capsid
disintegration resulting from 8C11 binding using a particle stability
thermal release assay (PaSTRy) (34) in which a dye is used to stain
the exposed genomic RNA of the native HEV (Fig. 4C) and is
read as changes in the fluorescence signal over incubation time (up
to 150 min). We found a gradual time-dependent increase in the
exposure of the HEV genome upon 8C11 binding until 90 min that
stabilized until the assay end point. The dynamic curve indicated
an inflection point at about 90 min that remained stable from then
on, almost comparable with the HPSEC analysis of the incubation
time required for complete VLP disassembly (2 h; Fig. 2A). In
contrast, for both the native virus alone and the 3B6-bound virus,
the fluorescence signal was maintained at a lower value below
the background level over the 150-min assay. These collective
biochemical and structural results support the hypothesis that
nAb 8C11 may neutralize HEV through a direct physical collision
mechanism.
Discussion
Pathogenic neutralization equips specific hosts with adaptive im-
munity against infection and/or subsequent disease onset. Immune
clearance usually requires immune recognition at vulnerable sites
of a virus (e.g., receptor-binding sites, metastable-associated sites,
among others); an antibody-mediated immune response; and the
presence of adaptive humoral and T-cell immunity against path-
ogens (5). Despite this capacity, the relatively bigger size of various
pathogens (several tens to hundreds of nanometers) generally
might exhaust great amounts of the host-immune system resources
to clear the pathogen, which could lead to secondary immune
events, as represented by various inflammatory responses, such as
hepatitis in the case of the hepatitis B virus, hepatisis C virus, and
HEV infection. To date, at least 5 viral neutralization mechanisms
have been identified, and this includes blocking cell attachment
through the use of antibodies that bind to specific viral receptor-
binding sites or cellular receptors (2, 3). Recent reports have
shown that antibodies can induce viral conformational changes
and drive uncoating and release of the genome in enteroviruses
(13, 14). For some enveloped viruses, such as HIV-1, antibody-
induced viral envelope protein dissociations will interfere with vi-
rion attachment to the target cell (12, 35). Unlike these conven-
tional mechanisms of neutralization, here, we show evidence for a
vigorous mode of antibody-mediated neutralization induced by the
physical disruption of the virus through antibody-imposed struc-
tural collisions. Here, we show that the 8C11 nAb physically
neutralizes the particulate pathogen into smaller dissociated spe-
cies, which might possibly be beneficial for the host-immune re-
sponse clearance as indicated in the immunology literature (7).
The spike of the HEV capsid, also referred to as the pro-
trusion domain or the E2s domain, is essential for virus-host
interactions (19, 21, 22). The spike comprises 2 representative
epitopes on the top or flanking side of the protrusion for anti-
body binding (Fig. 5). mAb 3B6 confers physically preferable
binding to the top of the E2s—believed to the viral receptor-
binding site—thereby blocking the virus from attaching to the
cell surface (21, 36). The 3B6-bound HEV retains its structural
integritywith the genome ensconced inside the capsid (Fig. 4 B
and C); such a complex is believed to be neutralized by con-
ventional Fc-dependent immune clearance (Fig. 5). The 3B6-like
antibodies are usually generated by the immunization of a native
virus, a VLP, or an intact/partial capsid protein (28). In com-
parison, mAb 8C11 binds to the flanking region of the E2s spike
with high affinity (5.89 nM) (23). However, this interaction then
distorts the icosahedral arrangement of the protrusion (at
Fig. 3. Cryo-EM structures of HEV VLP, VLP:8C11, and VLP:3B6. (A–C) A 3.4-Å cryo-EM structure of HEV VLPs. (A) The density map of the particle is colored
radially, and the particle diameter is indicated. (B) An asymmetric unit (ASU) and corresponding atomic model (P domain, green; M domain, orange; S domain,
magenta). (C) Typical cryo-EM map densities of an α-helix and β-sheet at 3.4-Å resolution. (D–F) A 3.6-Å cryo-EM structure of the VLP:8C11 complex incubated
for 15 min. (D) The density map of the complex shows a disordered spike region, and the diameter of the core region is indicated. (E) p495 model and crystal
structure of 8C11 Fab (blue) were fitted into the density of an ASU of the icosahedron. Few visible density regions can be matched to both the 8C11 Fab and
the P domain (highlighted in the dashed square), whereas the M and S domains of the p495 model fit into the VLP:8C11 density map as well as VLP only. (F)
Excellent model-fitted densities for the same parts of the α-helix and the β-sheet as (C). (G and H) A 7.2-Å cryo-EM map of the HEV:3B6 complex (G) and an
ASU fitted with the model of p495 (green) and 3B6 Fab (red) (H). The diameter of VLP:3B6 is indicated.
Zheng et al. PNAS | December 26, 2019 | vol. 116 | no. 52 | 26937
M
IC
RO
BI
O
LO
G
Y
D
ow
nl
oa
de
d 
at
 X
ia
m
en
 U
ni
ve
rs
ity
 o
n 
M
ar
ch
 5
, 2
02
0 
∼30 min, Fig. 3D) and squashes the VLP (51.3S) into smaller
pieces (7.5S) within 2 h (Fig. 2A and SI Appendix, Fig. S3), ex-
posing the RNA genome (Fig. 4C). Although there is no available
structural information for the mode of native virus dissociation
upon 8C11 binding, the T = 3 icosahedral structure of the HEV
VLPs (24)—believed to be virion-sized particles—showed similar
spatial overlapping in the presence of 8C11 binding (Fig. 1B),
implicating similar dissociation of the native HEV as that of VLPs.
Thus, 8C11 may function via a novel neutralization mechanism,
inducing a physical collision that disassembles HEV into smaller
pieces for immune clearance (Fig. 5). The containment and
elimination of these smaller pieces might require less effort from
the host-immune system as compared with the intact virus as
noted for 3B6 neutralization.
The protrusion spike is a common structure on the outermost
surfaces of enveloped (e.g., HIV and influenza virus) and non-
enveloped (e.g., HEV, rotavirus, and norovirus) viruses. Thus, the
use of 8C11-like antibodies for physical collision-mediated neu-
tralization is plausible for a range of viruses. To obtain 8C11-like
antibodies that neutralize and eliminate viruses by physical colli-
sion, we propose the following structure-guided strategy (Fig. 5)
(1): Perform a pattern search on the structures of both the spike
moiety and the virus as a whole; i.e., identify a structural concave
that is accessible for antibody binding at the flank of the spike but
unable to accommodate the entire antibody thereby facilitating the
probability of a physical collision; (2) generate mAbs through
immunization using only this spike [e.g., E2 in this study (37)], and
select mAbs with epitope mapping the flank of the protrusion
domain; (3) confirm virus dissociation and neutralization potency
through biochemical and virologic analyses; and (4) if possible,
enhance the binding affinity—for instance, using an affinity maturation
approach—to improve the potency of the antibody-mediated collision
for virus dissociation, which point is inferred from the fact that mAb
8C11 confers substantially stronger neutralization against HEV
genotype 1 rather than HEV genotype 4 in terms of its binding af-
finity of genotype 1 having 2 logarithms higher over that of genotype 4
(20, 23). This strategy could be extrapolated for the design of ligands
or antibodies that target more varied pathogens not just viruses.
Materials and Methods
Cells and Viruses. HepG2 (HB-8065, obtained from the ATCC, MD, USA) and
Huh7 S10-3 cells (kindly provided by Dr. Suzanne Emerson, NIH) were grown
in Eagle’s minimum essential medium (MEM, GIBCO) containing 10% FBS
(GIBCO, Australia) and antibiotics (10- U/mL ampicillin and 100-U/mL strep-
tomycin) (Lukang; Shandong, China) at 37 °C with 5% CO2. The HEV in-
fectious clone of the Kernow-C1 p6 (genotype 3) was kindly provided by
Suzanne Emerson (NIH). HEV stocks were generated by transfecting Huh7
S10-3 cells with in vitro transcribed anisotropic HEV genomic RNA.
Cloning, Expressing, and Purification. The ORF2 gene fragment of HEV ge-
notype 1, encoding residues 112–606, was cloned into pFastBac plasmid
(Invitrogen). Sf9 cells were transfected by lipofection to produce recombinant
viruses. Tn5 cells in ESF 921 were infected with the recombinant baculoviruses
for 4 d at 30 °C. The target proteins (p495) were mainly secreted into the
culture medium. p495 in the cell culture supernatant was concentrated by
incubation with 8% polyethylene glycol 6,000 in the presence of 0.4-M NaCl at
4 °C overnight. The precipitate was resuspended in 20-mM phosphate buffer
pH 6.0 (PB6.0) and purified using a diethylaminoethyl (DEAE)-5PW column.
Antibody and Fab Preparation. The nAbs used in this study were produced in
mouse ascites fluid and were affinity purified with a Protein A column. Fab
fragments were prepared from purified mouse monoclonal antibodies by
papain cleavage. A reducing L-cysteine buffer was used to activate the pa-
pain, and mAbs were mixed with papain at an appropriate molar ratio and
then incubated overnight at 37 °C. The reaction was stopped by the addition
of iodoacetamide, and the product was analyzed by SDS/PAGE. The Fab
fragments were purified using a TSK-GEL DEAE-5PW column. The Fc frag-
ments and uncleaved mAbs were trapped in the column, whereas, the Fab
fragments were collected in the flow-through component.
ELISA. The 96-well plates were coated with 100-ng/well p495 diluted in 20-mM
PB6.0 and, subsequently, incubated at 4 °C for 12 h. The plate was then
washed 5 times with PBS containing 0.05% Tween-20 (PBST buffer). The
wells were blocked with 200-μL/well blocking buffer (PBS + 0.25% casein
+1% gelatin +0.05% proclin-300) for 4 h at 37 °C. The plate was spin dried
and incubated with 100 μL/well of serially diluted antibody for 30 min at
37 °C. The wells were washed 5 times with PBST and then incubated with
100 μL/well of HRP-conjugated goat–anti-mouse IgG (1:5,000) for 30 min at
37 °C. The wells were again washed, incubated with substrate for color
development, and the absorbance read at 450 nm in a plate reader.
Neutralization Assay. Antibodies were incubated with the virus for 30 min at
37 °C before HepG2 cell inoculation. After 6 h, the inoculum was removed,
and the cells were washed 3 times with PBS, followed by incubation with
DMEM supplemented with 10% FBS and 2% DMSO. After 5 d, the cells were
stained with anti-HEV-ORF2monoclonal antibody. The neutralization efficiency
was determined by the number of infected cells in each condition. The data
were analyzed by nonlinear regression (GraphPad Prism, Inc.) to determine the
neutralization obtained with a given antibody concentration and the IC50.
PaSTRy. Thermofluor experiments (34) were performed with a MX2005p RT-
PCR instrument (Agilent). Environment-sensitive fluorescent dye SYTO9
(Invitrogen, S34854) was used to detect the presence of RNA. Each 50-μL
reaction was set up in a thin-walled PCR plate, containing 1.0-μg HEV native
virion, 5-μM SYTO9, and 3× SYPROred in PBS. The temperature ramped from
25 to 99 °C with the fluorescence level recorded in triplicate at 0.5-°C intervals.
In addition, a similar assay was also performed on virus-mAb complexes with
1.0-μg HEV native virion preincubated with 2.5-μg antibodies. The RNA release
Fig. 4. Property alteration of native HEV while binding with 8C11. (A) As-
sumed binding modality of 8C11 and 3B6 to native HEV (proposed T = 3) il-
lustrated according to the cocrystal structure of E2s:8C11 and the cryo-EM
structures of VLP:3B6 and T = 3 HEV VLP. One E2s monomer is colored green,
and the models of binding 8C11 and 3B6 Fabs are colored blue and red, re-
spectively. (B) Virus pelleting assay of native HEV pretreated with 8C11 and
3B6. Native HEV pretreated with 8C11 or 3B6 or alone were pelleted by ul-
tracentrifugation to quantify copy numbers of the RNA genome. Input column
in the histogram indicates the RNA genomic copy of native HEV before ul-
tracentrifugation. Results were statistically analyzed by an unpaired Student’s
t test. *P ≤ 0.05; ns, not significant (8C11 vs. 3B6, P < 0.0001; 8C11 vs. control,
P < 0.001; 3B6 vs. control, P = 0.6752 > 0.05). The decrease in RNA copy number
in the 8C11-treated sample as compared with the control suggests that half of
the native HEV changes to a smaller material that cannot be pelleted as an
intact virus. (C) Real-time PaSTRy assay of native HEV pretreated with 8C11 and
3B6. There is a trend for an increase in fluorescence from the dye bound to the
HEV RNA genome exposed by 8C11 binding; this indicates that the HEV capsid
is subjected to ongoing perturbation with 8C11 treatment over ∼60 min. The
fluorescent signal reaches a plateau early (∼60min) and remains there until the
assay end point (∼150 min). As for the controls, there were no substantial
changes in the fluorescence signals of 3B6 or the no-antibody control.
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(Tr) and melting temperature (Tm) were taken as theminima of the negative first
derivative of the RNA exposure and protein denaturation curves, respectively.
Virus Precipitation Assay. HEV virus from Rhesus monkey stools was prepared
in PBS. Viruses of 1.5 × 107 RNA copies were incubatedwith 10-μgmAb in 1-mL
PBS at 37 °C for 1 h. The mixtures were centrifuged on SW60 rotors at
31,000 rpm for 2 h at 4 °C. Pellets were suspended with 200-μL PBS to de-
termine the HEV RNA copy number. HEV RNA was purified from 50 μL of each
sample and the HEV RNA copy number was determined by quantitative real-
time reverse transcription–PCR (RT-PCR) as previously reported (38).
HPSEC. Purified HEV VLPs or complexes were subjected to HPLC (Agilent
Technologies 1200 series; Santa Clara, CA) through a TSK Gel G5000 pwxl
7.8 × 300-mm column (TOSOH, Tokyo, Japan) equilibrated in 20-mM PB6.0.
The column flow rate was maintained at 0.5 mL/min, and proteins in the eluents
were detected at 280 nm. To prepare the 8C11:VLP complex in the serial mixing
ratio, we maintained the same final amount of VLPs in the various mixtures,
whereas for the control, the 3B6 antibody was just added to the VLP sample
with an approximate molar ratio of 1:2 (p495 monomer:3B6 Fab).
Analytical Ultracentrifugation. SV was used to assess the homogeneity of p495
at 20 °C using a Beckman XL-A analytical ultracentrifuge equipped with ab-
sorbance optics and an An60-Ti rotor. The samples were diluted in 20-mM
PB6.0–0.83 OD280 nm. The speed was set at 30,000 rpm for analysis. The sed-
imentation coefficient was obtained using the c(s) method with the Sedifit
software (kindly provided by Dr. P. Schuck, National Institutes of Health,
http://www.analyticalultracentrifugation.com). As for the analysis of the
smaller complex fraction, the molecular weights were calculated from the
c(M) profile that was converted from the corresponding c(s) curve. Datasets
were processed using the program Origin for nonlinear least squares fit.
SDS/PAGE. Protein samples mixed with 2× loading buffer (100-mM Tris·HCl,
PH6.8, 4% SDS, 0.2% bromophenol blue, 200-mM DTT, 4% SDS, and 20%
glycerol) were subjected to 12% gradient SDS-polyacrylamide gel electro-
phoresis (SDS/PAGE). The proteins were stained by Coomassie Brilliant Blue
(Nacalai Tesque, Kyoto, Japan), according to standard laboratory protocols.
Negative-Staining Electron Microscopy. The purified HEV VLP and immune
complexes were diluted in PBS (pH 7.4) and then absorbed onto 200 mesh
carbon-coated copper grids (Quantifoil Micro Tools) for 1 min. The grids were
washed twice with double-distilled water and negatively stained with 2%
phosphotungstic acid (pH 6.4) for 30 s. Specimens were evaluated and imaged
with the FEI Tecnai T12 TEM at 25,000× magnification.
Cryo-EM Sample Preparation and Data Acquisition. VLP-Fab complexes were
prepared by incubating Fabs with VLPs at 37 °C. Aliquots (3 μL) of HEV VLP or
Fig. 5. Proposed viral neutralization mechanism of 8C11-mediated physical collision, and a strategy for the generation of 8C11-like mAbs. nAb 3B6, raised from
the immunization of HEV VLPs, possesses a conventional neutralization mechanism that directly blocks virus attachment to host cells, which, in some cases, binds to
a region that overlaps with receptor binding sites. The nAb-bound virus with no change in the integrity of the capsid then would be cleared by the elaborate host-
immune system. The nAb 8C11 was generated by the immunization of the partial capsid protein E2 and found to induce a physical collision when engaged with
the whole capsid. Eventually, the virus dissociates into small species and is likely then eliminated by the host-immune system, presumably with less effort. In short,
8C11-like mAbs could be produced by the immunization of a partial moiety of the pathogen, targeting a physically unfavorable binding region (e.g., positions
where the neighboring space cannot afford to accommodate an antibody) in the whole virus structure and thereby upsetting pathogenic infection in an immune-
favorable way. Proposed strategy for the generation of a collision-based neutralizing antibody is indicated by a step-by-step procedure flowchart in the Upper
Right, where every step is directed to the corresponding event that occurs in the antigen immunization and virus neutralization diagram.
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its complexes were deposited onto glow discharged holey carbon Quantifoil
Cu grids (R2/2, 200 mesh, Quantifoil Micro Tools) inside the FEI Mark IV
Vitrobot at a humidity level of 100%, blotted with filter papers for 6 s. The
grids were examined in a Tecnai G2 F30 TEM at 300 keV. The images were
recorded by an FEI Falcon II detector in the 17-frame movie mode with an
electron dose of ∼25 e-/Å2 at a calibrated magnification of 93,000.
Data Processing. Movie frames are aligned to correct the drift and beam-
induced motion with the program MotionCor2 (39), and the contrast
transfer function of each aligned micrograph was estimated with the pro-
gram Gctf (40). Particles from several representative micrographs were
manually boxed using the “e2boxer.py” program from the EMAN 2.1
package (41) as a reference for autopicking particles of the whole dataset
with the program Relion 2.0 (30). All extracted particle images were
subjected to multiple rounds of 2D classifications, and the classes exhibited
identifiable secondary structures, and those that were rated as “good” were
used to generate initial 3D models with the random model method in the
program AUTO3DEM (42). Particles were further processed for 3D image
reconstructions with Relion2.0. The resolutions of the maps were estimated
using gold-standard criteria with the Fourier shell correlation cutoff =
0.143 (43). Local resolution variations were estimated using the program
ResMap (44).
Model Building and Refinement. The atomic model of the HEV VLP was built
using the initial templates of the p495 crystal structure (PDB no. 2ZZQ). An initial
model generated frommolecular modelingwas docked into an asymmetric unit
(ASU) of the final cryo-EM map of HEV VLP using Chimera (45). Manual model
building and automatic refinement were alternately and iteratively performed
in Coot (46) and the module phenix_real_space_refine in PHENIX (46, 47). The
refined protomer was docked into the density of 6 neighboring ASUs, which
were then treated as a whole model for further optimization to avoid clashes
between ASUs. Model statistics, including bond lengths, bond angles, all atom
clashes, rotamer statistics, and Ramachandran plot statistics, etc., were closely
inspected with Coot. The final models were validated with Molprobity (48).
The atomic coordinates and structure factors of HEV VLP and VLV:8C11 were
deposited in the Protein Data Bank (PDB) with accession nos. 6LAT (49) and 6LB0
(50). The cryo-EM maps were deposited in the Electron Microscopy Data Bank
(EMDB) with accession nos. EMD-0863 (HEV VLP) (51), EMD-0866 (VLP:8C11)
(52), and EMD-0861 (VLP:3B6) (53). Figures were prepared with Chimera (45).
ACKNOWLEDGMENTS. This research was supported by grants from the
Natural Science Foundation of Fujian Province (Grant 2017J07005), the
National Science and Technology Major Project of Infectious Diseases (Grant
2018ZX10101001-002), and the National Natural Science Foundation of
China (Grants 81871247, 81991490, and 81571996).
1. S. A. Reading, N. J. Dimmock, Neutralization of animal virus infectivity by antibody.
Arch. Virol. 152, 1047–1059 (2007).
2. P. J. Klasse, Q. J. Sattentau, Occupancy and mechanism in antibody-mediated
neutralization of animal viruses. J. Gen. Virol. 83, 2091–2108 (2002).
3. W. A. Marasco, J. Sui, The growth and potential of human antiviral monoclonal an-
tibody therapeutics. Nat. Biotechnol. 25, 1421–1434 (2007).
4. D. R. Burton, Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2, 706–713 (2002).
5. L. L. Lu, T. J. Suscovich, S. M. Fortune, G. Alter, Beyond binding: Antibody effector
functions in infectious diseases. Nat. Rev. Immunol. 18, 46–61 (2018).
6. L. Hangartner, R. M. Zinkernagel, H. Hengartner, Antiviral antibody responses: The
two extremes of a wide spectrum. Nat. Rev. Immunol. 6, 231–243 (2006).
7. K. Murphy, C. Weaver, Janeway’s Immunobiology (Garland Science, ed. 9, 2017).
8. E. Lazear et al., Antibody-induced conformational changes in herpes simplex virus glyco-
protein gD reveal new targets for virus neutralization. J. Virol. 86, 1563–1576 (2012).
9. Q. Zheng et al., Atomic structures of enterovirus D68 in complex with two monoclonal
antibodies define distinct mechanisms of viral neutralization. Nat. Microbiol. 4, 124–
133 (2019).
10. T. C. Li et al., Essential elements of the capsid protein for self-assembly into empty
virus-like particles of hepatitis E virus. J. Virol. 79, 12999–13006 (2005).
11. J. L. Santos, J. A. Bispo, G. F. Landini, C. F. Bonafe, Proton dependence of tobacco
mosaic virus dissociation by pressure. Biophys. Chem. 111, 53–61 (2004).
12. J. L. Silva, G. Weber, Pressure-induced dissociation of brome mosaic virus. J. Mol. Biol.
199, 149–159 (1988).
13. Y. Dong et al., Antibody-induced uncoating of human rhinovirus B14. Proc. Natl.
Acad. Sci. U.S.A. 114, 8017–8022 (2017).
14. P. Plevka et al., Neutralizing antibodies can initiate genome release from human
enterovirus 71. Proc. Natl. Acad. Sci. U.S.A. 111, 2134–2139 (2014).
15. P. Brioen, B. Rombaut, A. Boeyé, Hit-and-run neutralization of poliovirus. J. Gen.
Virol. 66, 2495–2499 (1985).
16. I. Delaet, A. Boeyé, Monoclonal antibodies that disrupt poliovirus only at fever
temperatures. J. Virol. 67, 5299–5302 (1993).
17. K. C. McCullough et al., Conformational alteration in foot-and-mouth disease virus virion
capsid structure after complexing with monospecific antibody. Immunology 60, 75–82 (1987).
18. A. W. Tam et al., Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-
length viral genome. Virology 185, 120–131 (1991).
19. X. Yin et al., Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis
E virus infection. Proc. Natl. Acad. Sci. U.S.A. 115, 4773–4778 (2018).
20. Y. Gu et al., Structural basis for the neutralization of hepatitis E virus by a cross-
genotype antibody. Cell Res. 25, 604–620 (2015).
21. T. S. Guu et al., Structure of the hepatitis E virus-like particle suggests mechanisms for
virus assembly and receptor binding. Proc. Natl. Acad. Sci. U.S.A. 106, 12992–12997 (2009).
22. S. Li et al., Dimerization of hepatitis E virus capsid protein E2s domain is essential for
virus-host interaction. PLoS Pathog. 5, e1000537 (2009).
23. X. Tang et al., Structural basis for the neutralization and genotype specificity of
hepatitis E virus. Proc. Natl. Acad. Sci. U.S.A. 108, 10266–10271 (2011).
24. L. Xing et al., Structure of hepatitis E virion-sized particle reveals an RNA-dependent
viral assembly pathway. J. Biol. Chem. 285, 33175–33183 (2010).
25. T. Yamashita et al., Biological and immunological characteristics of hepatitis E virus-
like particles based on the crystal structure. Proc. Natl. Acad. Sci. U.S.A. 106, 12986–
12991 (2009).
26. D. J. Schofield, J. Glamann, S. U. Emerson, R. H. Purcell, Identification by phage display
and characterization of two neutralizing chimpanzee monoclonal antibodies to the
hepatitis E virus capsid protein. J. Virol. 74, 5548–5555 (2000).
27. L. Xing et al., Recombinant hepatitis E capsid protein self-assembles into a dual-
domain T = 1 particle presenting native virus epitopes. Virology 265, 35–45 (1999).
28. M. Zhao et al., A comprehensive study of neutralizing antigenic sites on the hepatitis
E virus (HEV) capsid by constructing, clustering, and characterizing a tool box. J. Biol.
Chem. 290, 19910–19922 (2015).
29. T. C. Li et al., Expression and self-assembly of empty virus-like particles of hepatitis E
virus. J. Virol. 71, 7207–7213 (1997).
30. S. H. Scheres, RELION: Implementation of a Bayesian approach to cryo-EM structure
determination. J. Struct. Biol. 180, 519–530 (2012).
31. M. Takahashi et al., Prolonged fecal shedding of hepatitis E virus (HEV) during spo-
radic acute hepatitis E: Evaluation of infectivity of HEV in fecal specimens in a cell
culture system. J. Clin. Microbiol. 45, 3671–3679 (2007).
32. T. Tanaka et al., Development and characterization of a genotype 4 hepatitis E virus
cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis
patient. J. Clin. Microbiol. 47, 1906–1910 (2009).
33. P. Shukla et al., Cross-species infections of cultured cells by hepatitis E virus and discovery of
an infectious virus-host recombinant. Proc. Natl. Acad. Sci. U.S.A. 108, 2438–2443 (2011).
34. T. S. Walter et al., A plate-based high-throughput assay for virus stability and vaccine
formulation. J. Virol. Methods 185, 166–170 (2012).
35. P. Poignard, T. Fouts, D. Naniche, J. P. Moore, Q. J. Sattentau, Neutralizing antibodies
to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein sub-
unit dissociation. J. Exp. Med. 183, 473–484 (1996).
36. S. He et al., Putative receptor-binding sites of hepatitis E virus. J. Gen. Virol. 89, 245–
249 (2008).
37. J. Zhang et al., Analysis of hepatitis E virus neutralization sites using monoclonal
antibodies directed against a virus capsid protein. Vaccine 23, 2881–2892 (2005).
38. P. G. Halbur et al., Comparative pathogenesis of infection of pigs with hepatitis
E viruses recovered from a pig and a human. J. Clin. Microbiol. 39, 918–923 (2001).
39. Z. Li et al., Crystal structures of two immune complexes identify determinants for viral in-
fectivity and type-specific neutralization of human papillomavirus.MBio 8, e00787-17 (2017).
40. K. Zhang, Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12
(2016).
41. G. Tang et al., EMAN2: An extensible image processing suite for electron microscopy.
J. Struct. Biol. 157, 38–46 (2007).
42. X. Yan, R. S. Sinkovits, T. S. Baker, AUTO3DEM–An automated and high throughput
program for image reconstruction of icosahedral particles. J. Struct. Biol. 157, 73–82 (2007).
43. S. H. Scheres, S. Chen, Prevention of overfitting in cryo-EM structure determination.
Nat. Methods 9, 853–854 (2012).
44. L. Swint-Kruse, C. S. Brown, Resmap: Automated representation of macromolecular
interfaces as two-dimensional networks. Bioinformatics 21, 3327–3328 (2005).
45. E. F. Pettersen et al., UCSF Chimera–A visualization system for exploratory research
and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
46. P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of Coot.
Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
47. P. D. Adams et al., PHENIX: A comprehensive Python-based system for macromolec-
ular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
48. V. B. Chen et al., MolProbity: All-atom structure validation for macromolecular crys-
tallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
49. Q. Zheng et al., The cryo-EM structure of HEV VLP. Protein Data Bank. http://www.rcsb.org/
structure/6LAT. Deposited 14 November 2019.
50. Q. Zheng et al., The cryo-EM structure of HEV VLP in complex with Fab 8C11. http://
www.rcsb.org/structure/6LB0. Deposited 14 November 2019.
51. Q. Zheng et al., The cryo-EM structure of HEV VLP. The Electron Microscopy Data
Bank. http://www.ebi.ac.uk/pdbe/entry/EMD-0863. Deposited 14 November 2019.
52. Q. Zheng et al., The cryo-EM structure of HEV VLP in complex with Fab 8C11. The
Electron Microscopy Data Bank. http://www.ebi.ac.uk/pdbe/entry/EMD-0866. Deposited
14 November 2019.
53. Q. Zheng et al., The cryo-EM structure of HEV VLP in complex with Fab 3B6. The
Electron Microscopy Data Bank. http://www.ebi.ac.uk/pdbe/entry/EMD-0861. Deposited
14 November 2019.
26940 | www.pnas.org/cgi/doi/10.1073/pnas.1916028116 Zheng et al.
D
ow
nl
oa
de
d 
at
 X
ia
m
en
 U
ni
ve
rs
ity
 o
n 
M
ar
ch
 5
, 2
02
0 
